Implications of pharmacogenomics for drug development and clinical practiceGINSBURG, Geoffrey S; KONSTANCE, Richard P; ALLSBROOK, Jennifer S et al.Archives of internal medicine (1960). 2005, Vol 165, Num 20, pp 2331-2336, issn 0003-9926, 6 p.Article

Effects of disclosing financial interests on participation in medical research : A randomized vignette trialWEINFURT, Kevin P; HALL, Mark A; FRIEDMAN, Joëlle Y et al.The American heart journal. 2008, Vol 156, Num 4, pp 689-697, issn 0002-8703, 9 p.Article

Effects of Disclosing Financial Interests on Attitudes Toward Clinical ResearchWEINFURT, Kevin P; HALL, Mark A; DINAN, Michaela A et al.Journal of general internal medicine. 2008, Vol 23, Num 6, pp 860-866, issn 0884-8734, 7 p.Article

Views of potential research participants on financial conflicts of interest : Barriers and opportunities for effective disclosureWEINFURT, Kevin P; FRIEDMAN, Joëlle Y; ALLSBROOK, Jennifer S et al.Journal of general internal medicine. 2006, Vol 21, Num 9, pp 901-906, issn 0884-8734, 6 p.Article

Costs of Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage. CommentaryCHOU, Chia-Hung; REED, Shelby D; ALLSBROOK, Jennifer S et al.Neurosurgery. 2010, Vol 67, Num 2, pp 345-352, issn 0148-396X, 8 p.Article

Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)REED, Shelby D; RADEVA, Jasmina I; SCHULMAN, Kevin A et al.The American heart journal. 2005, Vol 150, Num 2, pp 323-329, issn 0002-8703, 7 p.Article